These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma. Advani RH; Horning SJ; Hoppe RT; Daadi S; Allen J; Natkunam Y; Bartlett NL J Clin Oncol; 2014 Mar; 32(9):912-8. PubMed ID: 24516013 [TBL] [Abstract][Full Text] [Related]
15. Nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents--a comprehensive review of biology, clinical course and treatment options. Shankar A; Daw S Br J Haematol; 2012 Nov; 159(3):288-98. PubMed ID: 22994199 [TBL] [Abstract][Full Text] [Related]
16. Lymphocyte-Rich Classical Hodgkin Lymphoma. A Case with Difficulty in Distinguishing from Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Sakai J; Tanae K; Takahashi N; Nagata K; Yoshino T; Tamaru J; Niitsu N J Clin Exp Hematop; 2015; 55(1):23-8. PubMed ID: 26106003 [TBL] [Abstract][Full Text] [Related]
17. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma]. Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292 [TBL] [Abstract][Full Text] [Related]
19. CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center. Menke JR; Spinner MA; Natkunam Y; Warnke RA; Advani RH; Gratzinger DA Arch Pathol Lab Med; 2021 Jun; 145(6):753-758. PubMed ID: 32991677 [TBL] [Abstract][Full Text] [Related]
20. Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year follow-up in the West of Scotland Cancer Network. Farrell K; McKay P; Leach M Leuk Lymphoma; 2011 Oct; 52(10):1920-8. PubMed ID: 21663507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]